Physician profile
James C Brown
NPI 1881033793
$7,329.90
in general payments reported to CMS, 2019-2025
7 companies · $23.44 in 2025
The $23.44 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $2,420 · 2021: $385 · 2022: $82.46 · 2023: $3,101 · 2024: $419 · 2025: $23.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $654 · Travel and Lodging: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $654.32 |
| Travel and Lodging | $388.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,695.42 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $1,032.09 | 2019-2025 | Exalt Model D, General - Hemostasis |
| Medtronic, INC. | $385.11 | 2021 | |
| Janssen Pharmaceuticals, INC | $116.03 | 2023 | Xarelto |
| Haemonetics Corporation | $42.41 | 2022 | |
| Cerus Corporation | $40.05 | 2022 | |
| Glaxosmithkline, LLC. | $18.79 | 2023 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.